Decibel Therapeutics, Inc. DBTX
Trading inactive
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| SYMPHONY ACQUISITION SUB, INC. | DELAWARE | 0 | 0 | 0 | 0 | 0 | 0 % | 18/08/2023 |
| REGENERON PHARMACEUTICALS, INC. | NEW YORK | 2097314 | 0 | 2097314 | 0 | 2097314 | 8.3 % | 18/08/2023 |
| (1) BlackRock, Inc. | Delaware | 1805108 | 0 | 1805108 | 0 | 1805108 | 7.2 % | 03/02/2023 |
| Kevin P. Starr | 0 | 3139685 | 0 | 3139685 | 3139685 | 12.6 % | 14/02/2022 | |
| Third Rock Ventures GP III, L.P. | 0 | 3139685 | 0 | 3139685 | 3139685 | 12.6 % | 14/02/2022 | |
| Third Rock Ventures III, L.P. | 0 | 3139685 | 0 | 3139685 | 3139685 | 12.6 % | 14/02/2022 | |
| Robert I. Tepper | 0 | 3139685 | 0 | 3139685 | 3139685 | 12.6 % | 14/02/2022 | |
| TRV GP III, LLC | 0 | 3139685 | 0 | 3139685 | 3139685 | 12.6 % | 14/02/2022 | |
| Mark Levin | 0 | 3139685 | 0 | 3139685 | 3139685 | 12.6 % | 14/02/2022 | |
| Alphabet Holdings LLC | Delaware | 1636258 | 0 | 1636258 | 0 | 1636258 | 6.57 % | 14/02/2022 |
| GV 2017, L.P. | Delaware | 494649 | 0 | 494649 | 0 | 494649 | 1.98 % | 14/02/2022 |
| GV 2017 GP, L.P. | Delaware | 494649 | 0 | 494649 | 0 | 494649 | 1.98 % | 14/02/2022 |
| XXVI Holdings Inc. | Delaware | 1636258 | 0 | 1636258 | 0 | 1636258 | 6.57 % | 14/02/2022 |
| GV 2016, L.P. | Delaware | 321978 | 0 | 321978 | 0 | 321978 | 1.29 % | 14/02/2022 |
| Alphabet Inc. | Delaware | 1636258 | 0 | 1636258 | 0 | 1636258 | 6.57 % | 14/02/2022 |
| GV 2016 GP, L.P. | Delaware | 321978 | 0 | 321978 | 0 | 321978 | 1.29 % | 14/02/2022 |
| GV 2016 GP, L.L.C. | Delaware | 321978 | 0 | 321978 | 0 | 321978 | 1.29 % | 14/02/2022 |
| GV 2017 GP, L.L.C. | Delaware | 494649 | 0 | 494649 | 0 | 494649 | 1.98 % | 14/02/2022 |
| GV 2019, L.P. | Delaware | 819631 | 0 | 819631 | 0 | 819631 | 3.29 % | 14/02/2022 |
| GV 2019 GP, L.P. | Delaware | 819631 | 0 | 819631 | 0 | 819631 | 3.29 % | 14/02/2022 |
| GV 2019 GP, L.L.C. | Delaware | 819631 | 0 | 819631 | 0 | 819631 | 3.29 % | 14/02/2022 |
| 2. | 0 | 57738 | 0 | 0 | 10 | 0.2 % | 14/02/2022 | |
| 2. | 0 | 1827927 | 0 | 0 | 10 | 7.3 % | 14/02/2022 | |
| 2. | 0 | 1770189 | 0 | 0 | 10 | 7.1 % | 14/02/2022 | |
| 2. | 0 | 1770189 | 0 | 0 | 10 | 7.1 % | 14/02/2022 | |
| 2. | 0 | 1770189 | 0 | 0 | 10 | 7.1 % | 14/02/2022 | |
| 2. | 0 | 57738 | 0 | 0 | 10 | 0.2 % | 14/02/2022 | |
| 2. | 0 | 57738 | 0 | 0 | 10 | 0.2 % | 14/02/2022 | |
| REGENERON PHARMACEUTICALS, INC. 13-3444607 | New York | 2097314 | 0 | 2097314 | 0 | 2097314 | 8.42 % | 11/02/2022 |
| OrbiMed Capital LLC | Cayman Islands | 883418 | 0 | 883418 | 10 | 883418 | 3.6 % | 01/03/2021 |
| OrbiMed Genesis GP LLC | Cayman Islands | 0 | 218568 | 0 | 10 | 218568 | 0.9 % | 01/03/2021 |
| OrbiMed Capital GP VIII LLC | Delaware | 0 | 3843206 | 0 | 10 | 3843206 | 15.8 % | 01/03/2021 |
| OrbiMed Advisors LLC | Delaware | 0 | 4061774 | 0 | 10 | 4061774 | 16.7 % | 01/03/2021 |
| Citadel Securities GP LLC | Delaware | 0 | 47 | 0 | 0 | 10 | 12 % | 01/03/2021 |
| Citadel Securities LLC | Delaware | 0 | 47 | 0 | 0 | 10 | 12 % | 01/03/2021 |
| CALC IV LP | Delaware | 0 | 47 | 0 | 0 | 10 | 12 % | 01/03/2021 |
| Citadel Advisors Holdings LP | Delaware | 0 | 1788396 | 0 | 0 | 10 | 7.4 % | 01/03/2021 |
| Kenneth Griffin | Delaware | 0 | 1788443 | 0 | 0 | 10 | 7.4 % | 01/03/2021 |
| Citadel GP LLC | Delaware | 0 | 1788396 | 0 | 0 | 10 | 7.4 % | 01/03/2021 |
| Citadel Advisors LLC | Delaware | 0 | 1788396 | 0 | 0 | 10 | 7.4 % | 01/03/2021 |